In Singapore, colorectal cancer is the most commonly diagnosed cancer overall when both sexes are combined, according to the Singapore Cancer Registry Annual Report 2023. Regular screening may help reduce the risk of this disease developing by detecting and removing precancerous polyps before they transform into malignancies.
The disease develops in the colon or rectum, typically beginning as small, noncancerous polyps that evolve into malignant growths over several years. These cancers affect the large intestine’s lining cells, where genetic mutations — either acquired over time or inherited from parents cause abnormal cell development.
The disease progresses through distinct stages. It moves from localised tumours confined to the bowel wall to advanced cases involving lymph nodes or distant organs.
How Colorectal Cancer Develops
The colon and rectum form the final portion of the digestive tract. They process waste material before elimination. Cancer typically originates in glandular cells lining the intestinal wall. It forms adenocarcinomas (cancers that begin in gland-like cells). These malignant cells initially grow inward towards the intestinal cavity. They then progressively invade deeper tissue layers.
Polyps (small growths on the intestinal lining) serve as precursor lesions. Adenomatous polyps carry the highest transformation risk. This is particularly true for those larger than one centimetre or displaying villous architecture (a specific pattern of cell arrangement) under microscopic examination. The adenoma-to-carcinoma sequence typically spans five to ten years. However, certain genetic conditions accelerate this timeline significantly.
Tumour location influences both symptoms and treatment approaches. Right-sided colon cancers often grow larger before detection. This is because the bowel diameter is wider in this region, allowing tumours to expand without causing obstruction. Left-sided and rectal cancers frequently present earlier with bleeding or changes in bowel habits. This occurs due to the narrower intestinal passage.
Recognising Symptoms
Changes in Bowel Function
Persistent alterations in bowel habits warrant medical evaluation. These changes may include:
- New-onset constipation
- Diarrhoea
- Alternating between both patterns
Stools may appear narrower than usual. They are sometimes described as pencil-thin. This indicates potential narrowing of the intestinal passage.
A sensation of incomplete evacuation after bowel movements suggests possible rectal involvement. Patients may feel the urge to defecate but pass little stool. They may experience tenesmus (a persistent sensation of rectal fullness). These symptoms differ from temporary digestive disturbances by their persistence and progressive nature.
Bleeding and Anaemia
Blood in stool presents differently depending on tumour location. Rectal bleeding typically appears bright red. It coats the stool surface or appears visible on toilet paper. Cancers higher in the colon produce darker blood that mixes with stool. This sometimes creates a tarry appearance called melaena.
Chronic blood loss often occurs in quantities too small for visual detection. However, it is sufficient to cause iron-deficiency anaemia (low red blood cell count due to insufficient iron) over months. Resulting symptoms include:
- Unusual fatigue
- Shortness of breath during routine activities
- Pallor
Unexplained anaemia in adults necessitates colorectal evaluation. This is particularly true for men and postmenopausal women.
Systemic Warning Signs
Unintentional weight loss exceeding several kilograms over months may indicate advanced disease. Persistent abdominal discomfort can signal tumour growth affecting normal bowel function. This includes cramping, bloating, or a sense of fullness. Some patients experience decreased appetite. They may experience early satiety (feeling full after eating small amounts) when eating.
Abdominal pain that worsens over time or localises to a specific area deserves prompt attention. Severe symptoms suggest possible bowel obstruction requiring emergency care. These include complete inability to pass stool or gas, intense abdominal pain, or vomiting.
Risk Factors and Causes
Age and Family History
Risk increases substantially after age fifty. Singapore’s screening guidelines recommend colonoscopy (a screening test that uses a flexible tube with a camera to examine the entire colon) beginning at age fifty for average-risk individuals. It continues at ten-year intervals if results remain normal. For those opting for FIT testing instead, annual or biennial testing is generally recommended. Your doctor can advise on the most appropriate screening method based on your circumstances.
Family history significantly influences risk assessment. Having a first-degree relative diagnosed with colorectal cancer increases baseline risk. The risk amplifies further when multiple relatives are affected. It also increases when family members are diagnosed before age fifty. Genetic counselling helps identify families who may benefit from earlier or more frequent screening.
Inherited Genetic Conditions
Lynch syndrome, previously called hereditary nonpolyposis colorectal cancer, accounts for a small but significant proportion of cases. Individuals with Lynch syndrome carry mutations in DNA mismatch repair genes (genes that normally fix errors when DNA is copied). This substantially increases lifetime colorectal cancer risk. It also lowers the typical age of onset. Screening begins earlier and occurs more frequently in affected individuals.
Familial adenomatous polyposis causes a very large number of polyps throughout the colon. Near-certain cancer development occurs without intervention. This condition typically manifests in adolescence. Preventive colectomy (surgical removal of the colon) is often recommended in early adulthood. Genetic testing identifies at-risk family members before polyp development.
Lifestyle and Dietary Factors
Dietary patterns influence colorectal cancer risk through multiple mechanisms. High consumption of processed meats and red meat correlates with increased risk. This potentially occurs through compounds formed during cooking or preservation. Fibre-rich diets appear protective. This may happen by accelerating intestinal transit and reducing carcinogen contact time with the bowel lining.
Physical inactivity, obesity, and excessive alcohol consumption each independently elevate risk. Smoking affects colorectal cancer development through carcinogen exposure and chronic inflammation. These modifiable factors offer opportunities for risk reduction alongside appropriate screening.
? Did You Know?
The gut microbiome—many bacteria residing in your intestines—may influence colorectal cancer development. Certain bacterial species produce protective compounds from dietary fibre. Others generate potentially harmful metabolites from red meat consumption.
Diagnostic Evaluation
Colonoscopy
Colonoscopy is a diagnostic procedure for colorectal cancer. It allows direct visualisation of the entire colon and rectum. During this screening test, a doctor uses a flexible scope with camera and light source to examine the intestinal lining whilst the patient remains sedated. The doctor removes a small tissue sample for analysis from any suspicious lesions during the same procedure. This provides tissue for pathological analysis.
Bowel preparation before colonoscopy involves dietary restrictions and laxative consumption to clear the intestines. Bowel preparation can be the more challenging aspect of the process for some individuals, though modern reduced-volume preparations have helped improve tolerability for many patients. The procedure itself typically takes thirty to sixty minutes. Patients recover from sedation over one to two hours.
Imaging Studies
CT colonography, sometimes called virtual colonoscopy, uses computed tomography to create detailed colon images. This technique requires similar bowel preparation but avoids sedation and the scope itself. However, any abnormalities detected necessitate subsequent conventional colonoscopy for biopsy.
Staging investigations for confirmed cancers include CT scans of the chest, abdomen, and pelvis to assess potential spread. MRI provides superior detail for rectal cancers. This helps surgeons plan the extent of resection (the amount of tissue that needs to be removed). PET scans may identify metabolically active cancer deposits not visible on other imaging.
Tumour Markers and Genetic Testing
Carcinoembryonic antigen (CEA) blood levels (a protein that can be elevated in colorectal cancer) help monitor treatment response and detect recurrence. However, they’re not reliable for screening. Elevated CEA at diagnosis may indicate more advanced disease. It guides follow-up surveillance frequency.
Molecular testing of tumour tissue identifies genetic mutations affecting treatment selection. Microsatellite instability testing (which looks at patterns of DNA changes in the tumour) determines Lynch syndrome association. It also predicts immunotherapy response. RAS and BRAF mutation status influences chemotherapy drug selection for advanced disease.
Treatment Approaches
Surgical Intervention
Surgery is one of the treatment options for localised colorectal cancer. The surgeon removes the tumour along with surrounding healthy tissue and regional lymph nodes (small bean-shaped organs that filter lymph fluid). The extent of resection depends on tumour location. Procedures are named for the colon segment removed:
- Right hemicolectomy
- Left hemicolectomy
- Sigmoid colectomy
Minimally invasive techniques are associated with smaller incisions, reduced post-operative discomfort, and faster initial recovery in suitable candidates, though individual outcomes vary. These include laparoscopic and robotic-assisted surgery. Clinical evidence suggests these approaches can achieve comparable cancer outcomes whilst supporting short-term quality of life in appropriate cases. Open surgery remains necessary for some complex cases or emergency presentations.
Rectal cancer surgery requires particular expertise. This is due to the pelvis’s confined anatomy and proximity to urinary and sexual function nerves. Total mesorectal excision removes the rectum with its surrounding fatty envelope intact. This technique is associated with lower local recurrence rates. Some patients require temporary or permanent colostomy (a surgical opening that allows waste to exit through the abdominal wall into a bag). However, sphincter-preserving surgery is possible for many rectal cancers.
Chemotherapy
Adjuvant chemotherapy (treatment given after surgery to reduce the risk of cancer returning) following surgery may help reduce the risk of recurrence. It is used for stage III disease and selected stage II cases with high-risk features. Standard regimens combine fluorouracil-based drugs with oxaliplatin. Treatment typically occurs over six months. Treatment schedules vary between continuous infusion and intermittent dosing protocols.
Neoadjuvant chemotherapy (treatment given before surgery), given before surgery for rectal cancer, shrinks tumours to improve surgical outcomes. It potentially enables sphincter preservation. Combined with radiation therapy, this approach is commonly used for locally advanced rectal cancers. In some patients, pathological examination of surgical specimens has shown no residual cancer, though outcomes vary between individuals.
Palliative chemotherapy for metastatic disease (cancer that has spread to other parts of the body) aims to control growth, relieve symptoms, and extend survival. Multiple drug combinations exist. Selection depends on tumour molecular characteristics, prior treatments, and patient factors. A healthcare professional will determine the appropriate treatment approach based on individual circumstances. Response times vary depending on individual conditions. Treatment continues whilst providing benefit without unacceptable toxicity.
Radiation Therapy
External beam radiation therapy directs high-energy beams at cancer sites. It is typically combined with chemotherapy for rectal cancer treatment. Short-course radiation delivers higher daily doses over one week. Long-course treatment extends over five to six weeks with lower daily doses. Both approaches can reduce local recurrence.
Radiation may also palliate symptoms from advanced disease. These include bleeding, pain, or obstruction. Targeted radiation to limited metastatic sites in the liver or lungs may treat selected patients with oligometastatic disease (a small number of cancer deposits in one or two organs). Newer techniques like stereotactic body radiation therapy deliver precise, high-dose treatment to small tumour volumes.
Targeted and Immunotherapy
Targeted therapies block specific molecular pathways driving cancer growth. Anti-VEGF drugs inhibit blood vessel formation that tumours require for nutrients. Anti-EGFR antibodies work for tumours without RAS mutations. They block growth signals at the cell surface.
Immunotherapy has transformed treatment for microsatellite instability-high cancers. These account for a minority of colorectal cases but respond to checkpoint inhibitors. These drugs release immune system brakes. This enables recognition and destruction of cancer cells. Some patients with MSI-high metastatic disease have experienced durable remissions, though individual responses vary.
⚠️ Important Note
Liver metastases from colorectal cancer may be treatable with surgery in selected patients. Multidisciplinary evaluation by surgeons, oncologists, and radiologists determines resectability and optimal treatment sequencing.
Screening and Prevention Strategies
Colonoscopy screening (a test used to detect potential problems in healthy people) may help identify precancerous polyps that can be removed before malignant changes develop. For average-risk individuals, screening beginning at age fifty with ten-year intervals between normal examinations may help reduce colorectal cancer risk when performed at appropriate intervals. Those with family history or other risk factors require individualised earlier and more frequent screening schedules. Healthcare providers will determine these based on individual circumstances.
Faecal immunochemical testing (FIT) detects hidden blood in stool samples you collect at home. It offers a non-invasive annual screening alternative. Positive FIT results require colonoscopy follow-up. Whilst less sensitive than colonoscopy for polyps, regular FIT can identify cancers when performed consistently.
✅ Quick Tip
Keep a symptom diary if you notice bowel changes. Recording the nature, frequency, and duration of symptoms helps your doctor assess patterns. It helps determine appropriate investigation.
Living with Colorectal Cancer
Nutritional Considerations
Dietary modifications help manage treatment side effects. They also support maintaining strength during therapy. Small, frequent meals can help combat nausea and early satiety. Adequate protein intake supports tissue healing after surgery. Hydration is important for overall health, particularly when experiencing diarrhoea from chemotherapy or radiation.
Post-treatment dietary patterns should emphasise whole grains, vegetables, fruits, and lean proteins. They should limit processed and red meats. Some patients experience permanent changes in bowel function requiring ongoing dietary adjustments. Consultation with a dietitian can help develop sustainable eating patterns.
Psychological Support
Cancer diagnosis and treatment create significant emotional challenges for patients and families. Anxiety about treatment outcomes, body image concerns after ostomy surgery, and fear of recurrence are common experiences. Mental health support forms an integral component of comprehensive cancer care. This includes counselling, support groups, or psychiatric services.
Many patients find peer support valuable. They connect with others who have navigated similar experiences. Cancer support organisations provide education, practical assistance, and community connection. This continues throughout the treatment journey and survivorship period.
When to Seek Professional Help
- Blood in stool, whether bright red or dark and tarry
- Persistent change in bowel habits lasting more than several weeks
- Unexplained weight loss exceeding several kilograms
- New-onset abdominal pain or cramping that doesn’t resolve
- Unusual fatigue or weakness, particularly with pale appearance
- Family history of colorectal cancer, especially in relatives under fifty
- Previous polyps identified on colonoscopy
Commonly Asked Questions
How does colorectal cancer in Singapore compare to other countries in terms of detection?
Singapore has established comprehensive screening programmes through Screen for Life. This makes colonoscopy and FIT testing accessible. Early-stage detection rates have improved with increased screening uptake. However, participation remains below optimal levels.
What are the treatment outcomes for colorectal cancer?
Favourable long-term outcomes are possible for many patients, particularly those diagnosed at earlier stages when the disease is localised to the bowel wall. Even in some cases where the cancer has spread to the liver or lungs, surgical intervention combined with systemic therapy may achieve long-term disease control. Individual outcomes depend on disease stage, tumour characteristics, and overall health. Your specialist can provide a more personalised assessment.
How long does recovery take after colorectal surgery?
Hospital stays typically range from several days to one week for uncomplicated surgery. Full recovery to normal activities generally requires six to eight weeks, though less extensive procedures such as those for female haemorrhoids usually involve a much shorter recovery. However, this varies based on surgical extent, technique, and individual factors. Patients undergoing minimally invasive surgery often experience faster initial recovery.
What dietary changes help reduce colorectal cancer risk?
Increasing fibre intake through whole grains, vegetables, and fruits whilst reducing processed meat consumption may lower risk. Limiting alcohol, maintaining healthy body weight, and regular physical activity may provide additional protection. These lifestyle measures complement rather than replace appropriate screening.
Are all colon polyps cancerous?
Most polyps are benign and never become cancerous. Hyperplastic polyps, the most common type, carry minimal risk. Adenomatous polyps have cancer potential. However, only a small proportion actually transform. Removing adenomatous polyps during colonoscopy prevents their possible progression to cancer.
Next Steps
Early detection through screening is associated with more favourable treatment outcomes for colorectal cancer. Understanding your personal risk factors—including age, family history, and lifestyle factors—determines your optimal screening timeline. Colonoscopy can identify and remove precancerous polyps before they transform, whilst FIT testing provides a non-invasive annual screening alternative for average-risk individuals.
If you have concerns about your colorectal health or are unsure when to begin screening, our Senior Consultant Colorectal Surgeon is available to assess your individual risk profile and recommend an appropriate screening plan.
